Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The study found an improvement in seizure frequency of 52% in patients taking TPM compared to 38% in the placebo group
Other risks with IGF-1 treatment include headaches, intracranial hypertension, growth of the nasopharyngeal lymphoid tissues, hearing loss, and injection site lipohypertrophy [185,186,189,190]
GLP-1 is the target of many synthetic drugs on the market, initially developed in the treatment of type II diabetes, including: Exendin-4 (ELISA Product S-1297 , Rabbit anti-Exendin-4 Product T-4844 ): In the brain, it increases survival of dopamine neurons and decreases apoptosis of nerve cells, improving neuroplasticity
To alleviate the gastrointestinal reaction of patients, at the beginning of the application of these drugs, clinical workers should know that the dosage should be gradually increased from a small dosage to enhance patients tolerance
US$ 27.77
US$ 28.28
US$ 22.50
US$ 25.80
US$ 20.28
US$ 29.13
